63 related articles for article (PubMed ID: 32475629)
1. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
Bouza C; López-Cuadrado T; Alcázar R; Saz-Parkinson Z; Amate JM
BMC Gastroenterol; 2009 May; 9():31. PubMed ID: 19432967
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yang B; Zan RY; Wang SY; Li XL; Wei ML; Guo WH; You X; Li J; Liao ZY
World J Surg Oncol; 2015 Mar; 13():96. PubMed ID: 25889181
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
[TBL] [Abstract][Full Text] [Related]
4. Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Alitti C; Rode A; Trillaud H; Merle P; Blanc JF; Blaise L; Demory A; Nkontchou G; Grando V; Ziol M; Nahon P; Ganne-Carrié N; Petit A; Seror O; Sutter O; Nault JC
Liver Int; 2024 Jun; 44(6):1363-1372. PubMed ID: 38436538
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy.
Tada F; Hiraoka A; Nakatani K; Matsuoka K; Fukumoto M; Matsuda T; Yanagihara E; Saneto H; Murakami T; Onishi K; Izumoto H; Kitahata S; Kanemitsu-Okada K; Kawamura T; Kuroda T; Hanaoka J; Watanabe J; Ohtani H; Yoshida O; Hirooka M; Miyata H; Tsubouchi E; Abe M; Matsuura B; Ninomiya T; Hiasa Y
Clin J Gastroenterol; 2024 Jun; 17(3):401-411. PubMed ID: 38528198
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
Kim JI; Lee J; Choi GH; Lee MW; Park DA; Yoo JJ
Dig Dis Sci; 2024 Mar; 69(3):1055-1067. PubMed ID: 38300416
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Lau WY; Leung TW; Yu SC; Ho SK
Ann Surg; 2003 Feb; 237(2):171-9. PubMed ID: 12560774
[TBL] [Abstract][Full Text] [Related]
8. Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma.
Seo SH; Yu JI; Park HC; Yoo GS; Choi MS; Rhim H; Lee MW; Han S; Park B; Shim JS
Anticancer Res; 2024 May; 44(5):2219-2230. PubMed ID: 38677752
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations.
da Costa AC; Sodergren M; Jayant K; Santa Cruz F; Spalding D; Pai M; Habib N
World J Gastroenterol; 2020 May; 26(17):2040-2048. PubMed ID: 32536773
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).
Hendriks P; Rietbergen DDD; van Erkel AR; Coenraad MJ; Arntz MJ; Bennink RJ; Braat AE; Crobach S; van Delden OM; Dibbets-Schneider P; van der Hulle T; Klümpen HJ; van der Meer RW; Nijsen JFW; van Rijswijk CSP; Roosen J; Ruijter BN; Smit F; Stam MK; Takkenberg RB; Tushuizen ME; van Velden FHP; de Geus-Oei LF; Burgmans MC;
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2085-2097. PubMed ID: 38329507
[TBL] [Abstract][Full Text] [Related]
11. Can Machine Learning Predict Favorable Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma?
Hamed AA; Muhammed A; Abdelbary EAM; Elsharkawy RM; Ali MA
JCO Clin Cancer Inform; 2024 Mar; 8():e2300216. PubMed ID: 38531005
[TBL] [Abstract][Full Text] [Related]
12. Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapy.
Zhang F; Wu J; Zhang L; Zhang J; Yang R
J Pharm Biomed Anal; 2024 Jun; 243():116073. PubMed ID: 38484637
[TBL] [Abstract][Full Text] [Related]
13. Role of submucosal injection in radiofrequency ablation of gastric low-grade dysplasia: Effects on symptoms and outcomes.
Niu X; Wang N; Wang Y; Feng J; Li L; Han K; Chai N; Linghu E
Chin Med J (Engl); 2024 Apr; ():. PubMed ID: 38602084
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Hepatocellular Carcinoma in the Elderly: Slash or Burn?
Batsaikhan B; Dai CY
Dig Dis Sci; 2024 Mar; 69(3):662-663. PubMed ID: 38300417
[No Abstract] [Full Text] [Related]
15. Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma.
Zhou Q; Tuo F; Li R; Wang X; Wang J; Huang Z; Chen M; Huang J
Front Oncol; 2020; 10():578763. PubMed ID: 33251141
[TBL] [Abstract][Full Text] [Related]
16. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
Chang YJ; Chen LJ; Chang YJ; Chen PD
Eur J Surg Oncol; 2020 Sep; 46(9):1703-1710. PubMed ID: 32475629
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
Gut; 2005 Aug; 54(8):1151-6. PubMed ID: 16009687
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
